Welcome to Assay Development & High-throughput Screening
Venue: San Francisco
|Event Date/Time: Apr 05, 2006|
Asst. Sr Biologist, Cell Growth and Translational Genetics, Eli Lilly & Co.
Senior Automation Engineer, Pfizer Inc.
Changhua Ji, M.D., Ph.D.
Research Scientist II, Viral Disease Therapy, Roche Palo Alto
Senior Scientist, Department of Clinical Immunology, Amgen Inc.
Robert J. Pascoe, Ph.D.
Principal Scientist, RAS-Analytical, Merck & Co. Inc.
Dominique Perrin, Ph.D.
Group Leader, Biochemical Pharmacology, Serono Pharmaceutical Research Institute
GE Global Research Center
John Morin, Ph.D.
Director, High-Throughput Screening, Wyeth Research
Jun Wang, Ph.D.
Principal Scientist, Human Genetics Department, Roche Molecular Systems
Associate Director, Drug Lead Discovery, Chiron Corporation
Abraham Oommen, Ph.D.
Chief Executive Officer, GeneSeek AG
Christian Korherr, Ph.D.
Group Leader, Molecular and Cell Biology, Xantos Biomedicine AG
Robert Bostwick, Ph.D.
Assoc. Director & Head, Assay Development and HTS, Lead Generation, AstraZeneca Pharmaceuticals
Vincent Dupriez, Ph D.
Head, Molecular Biology & Assay Design, EUROSCREEN S.A.
Paul Lang, Ph.D.
Head, Cellular Pharmacology, Serono Pharmaceutical Research Institute
Daniel Johnson, Ph.D.
Senior Scientist, Assay Development, Amphora Corporation
University of Tübingen
Gloria Meng, Ph.D.
Assay and Automation Technology, Genentech Inc.
Bin Zhang, Ph.D.
Group leader and Principle Investigator, Dept of Chemical Biology, ArQule Inc.
Associate Director, Lead Discovery, Anadys Pharmaceuticals
Peter J. Tummino, Ph.D.
MMPD Enzymology & Mechanistic Pharmacology, GlaxoSmithKline Pharmaceuticals
Ron L. Johnson, Ph.D.
Team Leader, Molecular Genetic Assay Technologies, Biomolecular Screening and Profiling, NIH Chemical Genomics Center
Serene Josiah, Ph.D.
Consultant, Active Drug Design, LLC